Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.

HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. The objective was to identify factors associated with loss of virological control.HICs were identifi...

Full description

Bibliographic Details
Main Authors:	Fanny Chereau, Yoann Madec, Caroline Sabin, Niels Obel, Ezequiel Ruiz-Mateos, Georgios Chrysos, Sarah Fidler, Clara Lehmann, Robert Zangerle, Linda Wittkop, Peter Reiss, Osamah Hamouda, Vicente Estrada Perez, Manuel Leal, Amanda Mocroft, Patricia Garcia De Olalla, Adriana Ammassari, Antonella D'Arminio Monforte, Cristina Mussini, Ferran Segura, Antonella Castagna, Matthias Cavassini, Sophie Grabar, Philippe Morlat, Stéphane De Wit, Olivier Lambotte, Laurence Meyer, HIV Controllers Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCOORD
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5381858?pdf=render

Similar Items

CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
by: Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, et al.
Published: (2012-01-01)

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
by: Amanda Mocroft, et al.
Published: (2013-01-01)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
by: Camilla Tincati, et al.
Published: (2018-01-01)

Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients
by: Esther Merlini, et al.
Published: (2019-08-01)

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection.
by: Sara Lodi, et al.
Published: (2013-01-01)

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
by: Giota Touloumi, et al.
Published: (2013-01-01)

CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory.
by: Faroudy Boufassa, et al.
Published: (2011-01-01)

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.
by: Alexander Zoufaly, et al.
Published: (2014-01-01)

HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.
by: Benoît Vingert, et al.
Published: (2010-02-01)

Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
by: Francesca Bai, et al.
Published: (2012-01-01)

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
by: Dimitrios Paraskevis, et al.
Published: (2019-01-01)

Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration.
by: Faroudy Boufassa, et al.
Published: (2014-01-01)

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.
by: Giulia Marchetti, et al.
Published: (2012-01-01)

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.
by: Lars Peters, et al.
Published: (2013-01-01)

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study
by: Cristina Mussini, et al.
Published: (2018-05-01)

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.
by: Joanne Reekie, et al.
Published: (2012-01-01)

Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
by: Alberto L. Horenstein, et al.
Published: (2018-04-01)

Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapy.
by: Giusi Maria Bellistrì, et al.
Published: (2010-01-01)

Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010–2016
by: The Late Presentation Working Groups in EuroSIDA and COHERE
Published: (2020-10-01)

MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
by: Lander Egaña-Gorroño, et al.
Published: (2016-01-01)

Membrane Rafts in T Cell Activation: A Spotlight on CD28 Costimulation
by: Sara Zumerle, et al.
Published: (2017-11-01)

Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction.
by: Norbert Donhauser, et al.
Published: (2012-01-01)

Modulation of phenotype and function of human CD4+CD25+ T regulatory lymphocytes mediated by cAMP elevating agents
by: Antonella Riccomi, et al.
Published: (2016-09-01)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
by: Dario Roccatello, et al.
Published: (2020-06-01)

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.
by: Olivier Gasser, et al.
Published: (2007-03-01)

Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection
by: Tyler G. Normile, et al.
Published: (2021-09-01)

Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
by: Margalida Rotger, et al.
Published: (2010-02-01)

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
by: Cicconi Paola, et al.
Published: (2011-01-01)

Characterization of CD30/CD30L+ Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
by: Alessandro Barbieri, et al.
Published: (2015-01-01)

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.
by: Anne Marie W Efsen, et al.
Published: (2015-01-01)

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
by: Antonella d’Arminio Monforte, et al.
Published: (2020-10-01)

Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a+ CD4+ T Cells From Early HIV Infection to Effective cART
by: Sixtine Coindre, et al.
Published: (2018-06-01)

Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
by: Stéphane Hua, et al.
Published: (2014-01-01)

Value of CD16/CD66b/CD45 in comparison to CD55/CD59/CD45 in diagnosis of paroxysmal nocturnal haemoglobinuria: An Indian experience
by: Mrinalini Kotru, et al.
Published: (2017-01-01)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
by: Ashish Jagati, et al.
Published: (2017-01-01)

Interleukin-18 and CD30 serum levels in patients with moderate-severe depression
by: Rosaria Alba Merendino, et al.
Published: (2002-01-01)

CdTe, CdTe/CdS Core/Shell, and CdTe/CdS/ZnS Core/Shell/Shell Quantum Dots Study
by: Yan, Yueran
Published: (2012)

Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort.
by: Antonella d'Arminio Monforte, et al.
Published: (2016-01-01)

CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
by: Antonella Mancusi, et al.
Published: (2019-12-01)

Células CD3+, CD4+, CD8+, CD3-CD16+CD56+ e CD19+ em sangue periférico de pacientes com hanseníase e indivíduos saudáveis
by: Pinheiro, Catiússia Dantas
Published: (2016)